TrialStudy to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer
Trial details
- Registry ID
- NCT04262856
- Phase
- Phase 2
RCUS
Arcus Biosciences, Inc.
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
6Trials in this database
8Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity sourceStudy Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
Trial details
- Registry ID
- NCT04736173
- Phase
- Phase 2
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
Trial details
- Registry ID
- NCT05329766
- Phase
- Phase 2
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
Trial details
- Registry ID
- NCT05568095
- Phase
- Phase 3
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Trial details
- Registry ID
- NCT06608927
- Phase
- Phase 3
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Trial details
- Registry ID
- NCT07011719
- Phase
- Phase 3
Latest recorded trial changes
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
NCT05568095 · Arcus Biosciences, Inc.
Completion date type
Recorded edit− Previous value
Estimated
+ Updated value
Actual
Primary completion date
Recorded edit− Previous value
2026-08
+ Updated value
2026-08-28
Recruitment status
Recorded edit− Previous value
Active not recruiting
+ Updated value
Completed
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
NCT05568095 · Arcus Biosciences, Inc.
Primary completion date
Recorded edit− Previous value
2026-06
+ Updated value
2026-08
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer
NCT04262856 · Arcus Biosciences, Inc.
Primary completion date
Recorded edit− Previous value
2025-06-05
+ Updated value
2025-07-09
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
NCT05568095 · Arcus Biosciences, Inc.
Primary completion date
Recorded edit− Previous value
2026-12
+ Updated value
2026-06
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
NCT06608927 · Arcus Biosciences, Inc.
Recruitment status
Recorded edit− Previous value
Recruiting
+ Updated value
Active not recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719 · Arcus Biosciences, Inc.
Recruitment status
Recorded edit− Previous value
Not yet recruiting
+ Updated value
Recruiting